SCHEMBL305915

SCHEMBL305915

CCCCc1ccc(O)c(C=O)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.77
KAT8 Q9H7Z6 2/20 0.50
HPGD P15428 2/20 0.50
NPC1 O15118 1/20 0.50
MAPK1 P28482 1/20 0.50
HTT P42858 1/20 0.50
RAB9A P51151 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
IAPP P10997 1/20 0.47
PPARA Q07869 1/20 0.46
ERN1 O75460 4/20 0.46
CNR1 P21554 1/20 0.46
CNR2 P34972 1/20 0.46
IGF1R P08069 1/20 0.46
ALOX15 P16050 1/20 0.46
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
GPR84 Q9NQS5 1/20 0.44
ALDH1A1 P00352 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL305077 0.95 CDK1 (0.81) CDK1KAT8IAPPPPARAIGF1R
SCHEMBL304629 0.93 CDK1 (0.84) CDK1KAT8PPARAALDH1A1HSD17B10
SCHEMBL304974 0.93 CDK1 (0.84) CDK1KAT8PPARAALDH1A1HSD17B10
SCHEMBL27840244 0.93 CDK1 (0.84) CDK1KAT8PPARAALDH1A1HSD17B10
SCHEMBL9318508 0.93 CDK1 (0.84) CDK1KAT8PPARAALDH1A1HSD17B10
SCHEMBL304650 0.93 CDK1 (0.84) CDK1KAT8PPARAALDH1A1HSD17B10
SCHEMBL305081 0.93 CDK1 (0.84) CDK1KAT8PPARAALDH1A1HSD17B10
SCHEMBL6882282 0.93 CDK1 (0.84) CDK1KAT8PPARAALDH1A1HSD17B10
SCHEMBL11421416 0.93 CDK1 (0.84) CDK1KAT8PPARAALDH1A1HSD17B10
SCHEMBL11415237 0.93 CDK1 (0.84) CDK1KAT8PPARAALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1228356-C Norbornene polymerization catalyst system and its preparing process CHINESE ACAD INST CHEMISTRY (CN) 2005-11-23 CN claimed
CN-1200017-C Nickel compound catalyst system for polymerization of norbornene and its prepn CHINESE ACAD INST CHEMISTRY (CN) 2005-05-04 CN claimed
CN-1589136-A Pharmaceutical and cosmetic compositions containing aromatic aldehydes bearing oxygen-containing groups CUTANIX CORP (US) 2005-03-02 CN claimed
CN-1167720-C Polymeric catalyst system of norbornaene and its preparing process 中国科学院化学研究所 2004-09-22 CN claimed
CN-1139606-C Norbornene catalytic system and its preparation method and application 中国科学院化学研究所 2004-02-25 CN claimed
US-20030157154-A1 Compositions containing hydroxy aromatic aldehydes and their use in treatments CUTANIX CORPORATION 2003-08-21 US claimed
CN-1394685-A Norbornene catalytic system and its preparation method and application CHINESE ACAD INST CHEMISTRY (CN) 2003-02-05 CN claimed
CN-1390867-A Polymeric catalyst system of norbornaene and its preparing process CHINESE ACAD INST CHEMISTRY (CN) 2003-01-15 CN claimed
CN-1388140-A Nickel compound catalyst system for polymerization of norbornene and its prepn CHINESE ACAD INST CHEMISTRY (CN) 2003-01-01 CN claimed
CN-1388139-A Norbornene polymerization catalyst system and its preparing process CHINESE ACAD INST CHEMISTRY (CN) 2003-01-01 CN claimed
EP-0721482-B1 ADHESION PROMOTER FOR PVC COMPOUNDS DU PONT (US) 1997-11-05 EP claimed
EP-0530904-B1 A composition comprising a polymer of carbon monoxide and ethylenically unsaturated compounds SHELL INT RESEARCH (NL) 1997-03-05 EP claimed
US-5219954-A Improved ductility, flexural stiffness, modulus and tensile strength SHELL OIL COMPANY (US) 1993-06-15 US claimed
EP-0530904-A1 A composition comprising a polymer of carbon monoxide and ethylenically unsaturated compounds SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1993-03-10 EP claimed
US-9981901-B2 IRE-1α inhibitors FOSUN ORINOVE PHARMATECH, INC. (CN) 2018-05-29 US disclosed
US-20170152206-A1 IRE-1alpha INHIBITORS FOSUN ORINOVE PHARMATECH, INC. (CN) 2017-06-01 US disclosed
EP-3150589-A1 IRE-1A INHIBITORS MannKind Corporation (US) 2017-04-05 EP disclosed
US-4025490-A PRESSURE SENSITIVE MANIFOLD SYSTEMS THE MEAD CORPORATION (US) 1977-05-24 US disclosed
US-3978037-A POLYAMIDES CIBA-GEIGY CORPORATION (US) 1976-08-31 US disclosed
US-3953491-A ELECTROOPTICS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DT) 1976-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030157154-A1 Compositions containing hydroxy aromatic aldehydes and their use in treatments TYR, HRH1, HRH2 CDK1 4235/4885KAT8 832/4885HPGD 65/4885
US-20170152206-A1 IRE-1alpha INHIBITORS XBP1, DDIT3, ERN1 CDK1 1895/4885KAT8 4101/4885HPGD 1032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.